Studies related to Glycemic Control and Vitamin D

Vitamin D Supplementation Affects The Beck Depression Inventory, Insulin Resistance, And Biomarkers Of Oxidative Stress In Patients With Major Depressive Disorder: A Randomized, Controlled Clinical Trial

Effect Increase
Values Increased insulin sensitivity as measured by decreased insulin resistance via HOMA: (-1.0 for Vitamin D compared to +0.6 for placebo, p= 0.02)
Trial Design Randomized trial
Trial Length 1-6 months
Number of Subjects 40
Sex Both Genders
Age Range 18-29, 30-44, 45-64, 65+
Body Types Untrained, Average
Notes for this study:
In a randomized, double-blinded and placebo-controlled clinical trial high-dose vitamin D supplementation was shown to reduce depressive symptoms and improver markers for glucose homeostasis in individuals with major depressive disorder (MDD).